China, Aug. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening of Hub Genes and Research on Targeted Therapy for Cutaneous Melanoma Based on Multi-Omics'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130968
Registration Time: 2026/08/26
Type: Observational study
Primary Sponsor: Ankang Central Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340278
Published by HT Digital Content Services with permission from Health Daily Digest....